AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Baked US Russet potatoes
Number of subjects: 22
Study 12448388 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (vertical banded gastroplasty, Roux‐en‐Y gastric bypass, distal RYGBP)
Number of subjects: 45
Study 12448388 — intervention group
Group type: COMPARATOR
Intervention: Non-operated morbidly obese controls
Number of subjects: 45
Study 12448388 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (all types)
Number of subjects: 45
Study 12448388 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 45
Study 10319352 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (three different methods)
Number of subjects: 65
Study 10319352 — intervention group
Group type: COMPARATOR
Intervention: Control (16 patients observed without treatment)
Number of subjects: 65
Study 9172005 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation A (furosemide, 500 mg)
Number of subjects: 15
Study 9172005 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation B (furosemide, 500 mg)
Number of subjects: 15
Study 1479049 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 8
Study 1479049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6398127 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPN) 375 mg
Number of subjects: 90
Study 6398127 — intervention group
Group type: COMPARATOR
Intervention: Low-dose metoclopramide (MCP) 60 mg
Number of subjects: 90
Study 30547350 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia (defined by insomnia severity index score ≥ 10)
Number of subjects: 603
Study 30547350 — intervention group
Group type: COMPARATOR
Intervention: Non-insomnia group
Number of subjects: 603
Study 30547350 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with insomnia
Number of subjects: 603
Study 30547350 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with insomnia
Number of subjects: 603
Study 28988340 — intervention group
Group type: EXPERIMENTAL
Intervention: Core decompression plus BMAC implantation
Number of subjects: 46
Study 28988340 — intervention group
Group type: COMPARATOR
Intervention: Core decompression plus saline injection
Number of subjects: 46
Study 26338095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every two weeks (120 Q2W)
Number of subjects: 1164
Study 26338095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every four weeks (120 Q4W)
Number of subjects: 1164
Study 26338095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1164
Study 26338095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tabalumab (both dosing regimens)
Number of subjects: 1164
Study 26338095 — intervention group
Group type: COMPARATOR
Intervention: Tabalumab and placebo
Number of subjects: 1164
Study 24991973 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-session HIV/HCV/STI prevention intervention (risk reduction: RR)
Number of subjects: 600
Study 24991973 — intervention group
Group type: COMPARATOR
Intervention: 5-session Wellness Promotion (WP) intervention
Number of subjects: 600
Study 21944671 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 50
Study 21944671 — intervention group
Group type: COMPARATOR
Intervention: Voglibose
Number of subjects: 50
Study 20022995 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfortable gait speed (CGS) improvement
Number of subjects: 283
Study 18184932 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training (n = 11)
Number of subjects: 21
Study 18184932 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive movement protocol (n = 10)
Number of subjects: 21
Study 16925195 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intravenous ketorolac (Toradol), 0.25% subcutaneous bupivacaine (Marcaine) with epinephrine along the incision, and 0.25% bupivacaine in the rectus fascia
Number of subjects: 20
Study 16925195 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 20
Study 12647074 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorus-preserving Whipple
Number of subjects: 150000
Study 12647074 — intervention group
Group type: COMPARATOR
Intervention: Classical Whipple
Number of subjects: 150000
Study 12647074 — intervention group
Group type: COMPARATOR
Intervention: Extended lymph node dissection
Number of subjects: 150000
Study 10860185 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 1000
Study 10860185 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1000
Study 10860185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 8880843 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic experimental muscle pain
Number of subjects: 20
Study 8880843 — intervention group
Group type: COMPARATOR
Intervention: Sham pain
Number of subjects: 20
Study 1387778 — intervention group
Group type: EXPERIMENTAL
Intervention: Inocoterone 10% solution
Number of subjects: 126
Study 1387778 — intervention group
Group type: COMPARATOR
Intervention: Vehicle solution
Number of subjects: 126
Study 6830136 — intervention group
Group type: EXPERIMENTAL
Intervention: Op-Site skin closure
Number of subjects: 0
Study 6830136 — intervention group
Group type: COMPARATOR
Intervention: Interrupted silk sutures
Number of subjects: 0
Study 6830136 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular nylon
Number of subjects: 0
Study 30357272 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 1.6 mg/kg
Number of subjects: 301
Study 30357272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 30357272 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 0.4 mg/kg
Number of subjects: 301
Study 30357272 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 0.8 mg/kg
Number of subjects: 301
Study 26400845 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational nursing program over 9 months
Number of subjects: 61
Study 24438438 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AEx)
Number of subjects: 200
Study 24438438 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (LCh)
Number of subjects: 200
Study 24438438 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise + Low carbohydrate diet (AEx + LCh)
Number of subjects: 200
Study 24438438 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study 23390781 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination 5-fluoruracil (5-FU) with cisplatinum
Number of subjects: 88
Study 23390781 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 5-fluoruracil (5-FU) regimen
Number of subjects: 88
Study 23390781 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 88
Study 23390781 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum with 5-FU
Number of subjects: 88
Study 23390781 — intervention group
Group type: COMPARATOR
Intervention: 5-FU regimen
Number of subjects: 88
Study 19439098 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Laser Disc Decompression (PLDD)
Number of subjects: 0
Study 19439098 — intervention group
Group type: COMPARATOR
Intervention: Conventional open discectomy
Number of subjects: 0
Study 17469917 — intervention group
Group type: EXPERIMENTAL
Intervention: Place training
Number of subjects: 0
Study 17469917 — intervention group
Group type: EXPERIMENTAL
Intervention: Response training
Number of subjects: 0
Study 17469917 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0
Study 17469917 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 0
Study 16237467 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for gastric cancer
Number of subjects: 137
Study 16237467 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal gastrectomy
Number of subjects: 137
Study 16237467 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 137
Study 11888754 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg/24 h P.O. + 2x0.5 mg digoxin IV on the operating day + digoxin 0.25 mg P.O. + metoprolol 100 mg P.O. on the first postoperative day until discharge
Number of subjects: 241
Study 11888754 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone 1200 mg IV/24 h (300 mg bolus dose/1 h post-operation, then 450 mg/24 h IV and 600 mg/day P.O. until discharge)
Number of subjects: 241
Study 11888754 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic prophylaxis
Number of subjects: 241
Study 10468706 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 9
Study 10468706 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose
Number of subjects: 9
Study 10468706 — intervention group
Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 9
Study 10468706 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide production
Number of subjects: 9
Study 8597006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 2.5 mg/kg/d
Number of subjects: 10
Study 8597006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 5.0 mg/kg/d
Number of subjects: 10
Study 8597006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 10
Study 1817786 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum information on local anesthesia
Number of subjects: 240
Study 1817786 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic information on local anesthesia
Number of subjects: 240
Study 1817786 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended information on local anesthesia
Number of subjects: 240
Study 1817786 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study 7156449 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% N2O‐‐75% O2
Number of subjects: 9
Study 7156449 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% N2O‐‐50% O2
Number of subjects: 9
Study 7156449 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 9
Study 31079146 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Sinovac
Number of subjects: 14
Study 31079146 — intervention group
Group type: COMPARATOR
Intervention: Group CAMS
Number of subjects: 14
Study 31079146 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 14
Study 29921405 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic reposition treatment
Number of subjects: 60
Study 29921405 — intervention group
Group type: COMPARATOR
Intervention: Manual reposition treatment
Number of subjects: 60
Study 26838074 — intervention group
Group type: EXPERIMENTAL
Intervention: XueBiJing injection (intravenous infusion)
Number of subjects: 0
Study 24467711 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated Roux loop pancreaticojejunostomy (IRPJ)
Number of subjects: 90
Study 24467711 — intervention group
Group type: COMPARATOR
Intervention: Pancreaticogastrostomy (PG)
Number of subjects: 90
Study 23271772 — intervention group
Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 1500
Study 23271772 — intervention group
Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 1500
Study 23271772 — intervention group
Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 1500
Study 19356901 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental variable analysis
Number of subjects: 0
Study 17172550 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 23
Study 17172550 — intervention group
Group type: COMPARATOR
Intervention: Intensive traditional therapy
Number of subjects: 23
Study 15678729 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion (5 mg kg(‐1) bolus followed by 500 mg h(‐1) infusion for 24 h)
Number of subjects: 50
Study 15678729 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline infusion in the same volumes for 24 h)
Number of subjects: 50
Study 12201932 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg/day)
Number of subjects: 28
Study 12201932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9619458 — intervention group
Group type: COMPARATOR
Intervention: Gamma nail
Number of subjects: 170
Study 9619458 — intervention group
Group type: COMPARATOR
Intervention: Compression hip screw (CHS)
Number of subjects: 170
Study 9619458 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic hip screw with a laterally mounted trochanteric stabilizing plate (DHS/TSP)
Number of subjects: 170
Study 7649315 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 104
Study 2696196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernous noradrenaline (10 micrograms per hour)
Number of subjects: 20
Study 2696196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 420135 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (155 cal and 20 g of protein per day)
Number of subjects: 0
Study 420135 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 0
Study 31126835 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 98
Study 31126835 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 98
Study 27898575 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for early syphilis
Number of subjects: 369
Study 27898575 — intervention group
Group type: COMPARATOR
Intervention: Male sex
Number of subjects: 369
Study 27898575 — intervention group
Group type: COMPARATOR
Intervention: Baseline RPR titers ≤ 1:32
Number of subjects: 369
Study 26108088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray (FPNS) 200 mcg once daily
Number of subjects: 682
Study 26108088 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 682
Study 26108088 — intervention group
Group type: COMPARATOR
Intervention: FPNS placebo
Number of subjects: 682
Study 26108088 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine placebo
Number of subjects: 682
Study 23648948 — intervention group
Group type: EXPERIMENTAL
Intervention: BSS+ (Behavioral Support Sessions plus bupropion therapy)
Number of subjects: 1955
Study 23648948 — intervention group
Group type: EXPERIMENTAL
Intervention: BSS (Behavioral Support Sessions)
Number of subjects: 1955
Study 23648948 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1955
Study 21369950 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam 16 mg
Number of subjects: 50
Study 21369950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19402296 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D injection (600,000 IU)
Number of subjects: 82
Study 17367443 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical verapamil hydrochloride 15% gel applied twice daily for 3 months, followed by open label for 6 months.
Number of subjects: 57
Study 17367443 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo) not specified in detail.
Number of subjects: 57
Study 15599680 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenite
Number of subjects: 70
Study 15599680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 11563779 — intervention group
Group type: EXPERIMENTAL
Intervention: Suramin
Number of subjects: 10
Study 11563779 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin
Number of subjects: 10
Study 11563779 — intervention group
Group type: COMPARATOR
Intervention: Without Mitomycin
Number of subjects: 10
Study 9039201 — intervention group
Group type: EXPERIMENTAL
Intervention: Butenafine 1% cream applied once daily for 2 weeks
Number of subjects: 93
Study 9039201 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control applied once daily for 2 weeks
Number of subjects: 93
Study 7892940 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferroplex
Number of subjects: 0
Study 7892940 — intervention group
Group type: EXPERIMENTAL
Intervention: Feramide
Number of subjects: 0
Study 7892940 — intervention group
Group type: EXPERIMENTAL
Intervention: Conferon
Number of subjects: 0
Study 3587619 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithin
Number of subjects: 10
Study 3587619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29572629 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge core biopsy needle with a stylet (S+)
Number of subjects: 114
Study 29572629 — intervention group
Group type: COMPARATOR
Intervention: 25-gauge core biopsy needle without a stylet (S-)
Number of subjects: 114
Study 27306272 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy for Insomnia (GT)
Number of subjects: 62
Study 27306272 — intervention group
Group type: COMPARATOR
Intervention: Internet Cognitive Behavioral Therapy for Insomnia (IT)
Number of subjects: 62
Study 25261882 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 60
Study 25261882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23511116 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 19
Study 23511116 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment
Number of subjects: 19
Study 28555208 — intervention group
Group type: EXPERIMENTAL
Intervention: One-piece implants (OPI)
Number of subjects: 38
Study 28555208 — intervention group
Group type: COMPARATOR
Intervention: Two-piece implants (TPI)
Number of subjects: 38
Study 28555208 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OPI and TPI
Number of subjects: 38
Study 18779548 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Management intervention (including naltrexone and acamprosate)
Number of subjects: 0
Study 18779548 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Management intervention
Number of subjects: 0
Study 17157118 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine
Number of subjects: 66
Study 17157118 — intervention group
Group type: COMPARATOR
Intervention: Epinastine
Number of subjects: 66
Study 14588129 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter plus follow-up letter
Number of subjects: 100
Study 14588129 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter plus follow-up phone call
Number of subjects: 100
Study 14588129 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone call plus follow-up phone call
Number of subjects: 100
Study 14588129 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 100
Study 14588129 — intervention group
Group type: COMPARATOR
Intervention: Cervical cancer screening outreach (Control)
Number of subjects: 100
Study 14588129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cancer screening outreach with letter reminders
Number of subjects: 100
Study 10920316 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned cesarean delivery
Number of subjects: 497
Study 10920316 — intervention group
Group type: EXPERIMENTAL
Intervention: Other cesarean delivery
Number of subjects: 497
Study 10920316 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 497
Study 10920316 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 count <200/microL
Number of subjects: 497
Study 10920316 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 count >=200/microL
Number of subjects: 497
Study 8933483 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (4 sessions per week at 60-80% of maximal heart rate)
Number of subjects: 16
Study 8933483 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 men)
Number of subjects: 16
Study 1579326 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (missing pills on days 1-4)
Number of subjects: 15
Study 1579326 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (missing pills on days 3-6)
Number of subjects: 15
Study 1579326 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (missing pills on days 6-9)
Number of subjects: 15
Study 1579326 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (combined results)
Number of subjects: 15
Study 3887499 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensation information
Number of subjects: 113
Study 3887499 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-instruction information
Number of subjects: 113
Study 3887499 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sensation and self-instruction information
Number of subjects: 113
Study 3887499 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 113
Study 31309643 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day sesamin supplement
Number of subjects: 44
Study 31309643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 30355140 — intervention group
Group type: EXPERIMENTAL
Intervention: Target BP of ≈130/80 mm Hg in all hypertensive patients (based on HOT, ACCORD, SPS3 studies)
Number of subjects: 0
Study 30355140 — intervention group
Group type: EXPERIMENTAL
Intervention: Target BP of <140/90 mm Hg in most diabetes mellitus patients, <130/80 mm Hg in selected patients (American Diabetes Association guidelines)
Number of subjects: 0
Study 30355140 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving <140 mm Hg systolic BP
Number of subjects: 0
Study 27461767 — intervention group
Group type: COMPARATOR
Intervention: TIVA0 (manual infusion guided by clinical signs)
Number of subjects: 66
Study 27461767 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVABIS (BIS-guided infusion)
Number of subjects: 66
Study 27461767 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI KBIS (BIS-guided target controlled infusion with Kataria model)
Number of subjects: 66
Study 27461767 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI SBIS (BIS-guided target controlled infusion with Schnider model)
Number of subjects: 66
Study 27461767 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI SBIS compared to TCI KBIS
Number of subjects: 66
Study 24528939 — intervention group
Group type: EXPERIMENTAL
Intervention: HPLC diet (very low carbohydrate, 22 g/d)
Number of subjects: 12